Physicians Formula Holdings Inc. Stock Upgraded (FACE)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

NEW YORK ( TheStreet) -- Physicians Formula Holdings (Nasdaq: FACE) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, good cash flow from operations, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

Highlights from the ratings report include:
  • The revenue growth came in higher than the industry average of 3.4%. Since the same quarter one year prior, revenues rose by 24.0%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • The gross profit margin for PHYSICIANS FORMULA HOLDINGS is rather high; currently it is at 55.70%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 9.30% is above that of the industry average.
  • Net operating cash flow has significantly increased by 204.01% to $6.21 million when compared to the same quarter last year. In addition, PHYSICIANS FORMULA HOLDINGS has also vastly surpassed the industry average cash flow growth rate of -8.36%.
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Personal Products industry. The net income increased by 437.5% when compared to the same quarter one year prior, rising from $0.45 million to $2.42 million.
  • FACE's debt-to-equity ratio is very low at 0.07 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.72 is somewhat weak and could be cause for future problems.

Physicians Formula Holdings, Inc. develops, markets, and sells cosmetic and skin care products for the mass market channel. The company has a P/E ratio of 22.4, equal to the average consumer non-durables industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Physicians Formula has a market cap of $58.3 million and is part of the consumer goods sector and consumer non-durables industry. Shares are up 32.8% year to date as of the close of trading on Thursday.

You can view the full Physicians Formula Ratings Report or get investment ideas from our investment research center.

-- Written by a member of TheStreet Ratings Staff

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers